SEC FORM 4
$4,564.67
Beam Therapeutics Inc. (BEAM)
Sale of 187 shares at $24.41 per share.
Reporting Person Cavanagh Bethany J · Officer Title SVP, Finance and Treasurer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001193125-26-412236 · filed 2026-10-02 · View filing →